Corient Private Wealth
KMTS

Corient Private Wealth’s Kestra Medical Technologies KMTS Stock Holding History

Corient Private Wealth’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
60,614
+44,839
+284% +$939K ﹤0.01% 1548
2026
Q1 		$314K Buy
+15,775
New +$372K ﹤0.01% 2302

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Corient Private Wealth's KMTS Position: Q2 2026 in Review

Corient Private Wealth increased its Kestra Medical Technologies (KMTS) stake by 284% in Q2 2026, buying an estimated $939K and bringing the position to 60,614 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Corient Private Wealth first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Corient Private Wealth held 60,614 shares of Kestra Medical Technologies worth $1.54M as of Q2 2026.
  • Corient Private Wealth bought 44,839 Kestra Medical Technologies shares in Q2 2026, an estimated $939K.
  • Kestra Medical Technologies made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1548 holding.
  • Corient Private Wealth first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.